Literature DB >> 33705745

International Liver Cancer Association (ILCA) White Paper on Biomarker Development for Hepatocellular Carcinoma.

Amit G Singal1, Yujin Hoshida2, David J Pinato3, Jorge Marrero2, Jean-Charles Nault4, Valerie Paradis5, Nabihah Tayob6, Morris Sherman7, Young Suk Lim8, Ziding Feng9, Anna S Lok10, Jo Ann Rinaudo11, Sudhir Srivastava11, Josep M Llovet12, Augusto Villanueva13.   

Abstract

Entities:  

Keywords:  Biomarkers; Cirrhosis; Liver Cancer

Mesh：

Substances：

Year:  2021        PMID： 33705745      PMCID： PMC8169638          DOI： 10.1053/j.gastro.2021.01.233

Source DB:  PubMed          Journal:  Gastroenterology        ISSN： 0016-5085            Impact factor:   33.883


× No keyword cloud information.
  72 in total

1.  Tivantinib for second-line treatment of MET-high, advanced hepatocellular carcinoma (METIV-HCC): a final analysis of a phase 3, randomised, placebo-controlled study.

Authors:  Lorenza Rimassa; Eric Assenat; Markus Peck-Radosavljevic; Marc Pracht; Vittorina Zagonel; Philippe Mathurin; Elena Rota Caremoli; Camillo Porta; Bruno Daniele; Luigi Bolondi; Vincenzo Mazzaferro; William Harris; Nevena Damjanov; Davide Pastorelli; María Reig; Jennifer Knox; Francesca Negri; Jörg Trojan; Carlos López López; Nicola Personeni; Thomas Decaens; Marie Dupuy; Wolfgang Sieghart; Giovanni Abbadessa; Brian Schwartz; Maria Lamar; Terri Goldberg; Dale Shuster; Armando Santoro; Jordi Bruix
Journal:  Lancet Oncol       Date:  2018-04-03       Impact factor: 41.316

2.  Plasma biomarkers as predictors of outcome in patients with advanced hepatocellular carcinoma.

Authors:  Josep M Llovet; Carol E A Peña; Chetan D Lathia; Michael Shan; Gerold Meinhardt; Jordi Bruix
Journal:  Clin Cancer Res       Date:  2012-02-28       Impact factor: 12.531

3.  Relationship between baseline hepatic status and outcome, and effect of sorafenib on liver function: SHARP trial subanalyses.

Authors:  Jean-Luc Raoul; Jordi Bruix; Tim F Greten; Morris Sherman; Vincenzo Mazzaferro; Philip Hilgard; Hans Scherubl; Max E Scheulen; Georgios Germanidis; Sophie Dominguez; Sergio Ricci; Andrea Nadel; Marius Moscovici; Dimitris Voliotis; Josep M Llovet
Journal:  J Hepatol       Date:  2012-01-13       Impact factor: 25.083

4.  Cost Effectiveness of Hepatocellular Carcinoma Surveillance After a Sustained Virologic Response to Therapy in Patients With Hepatitis C Virus Infection and Advanced Fibrosis.

Authors:  Hooman Farhang Zangneh; William W L Wong; Beate Sander; Chaim M Bell; Khalid Mumtaz; Matthew Kowgier; Adriaan J van der Meer; Sean P Cleary; Harry L A Janssen; Kelvin K W Chan; Jordan J Feld
Journal:  Clin Gastroenterol Hepatol       Date:  2018-12-20       Impact factor: 11.382

5.  Estrogen receptors and breast cancer response to adrenalectomy.

Authors:  E V Jensen; G E Block; S Smith; K Kyser; E R DeSombre
Journal:  Natl Cancer Inst Monogr       Date:  1971-12

6.  A hepatocellular carcinoma 5-gene score associated with survival of patients after liver resection.

Authors:  Jean-Charles Nault; Aurélien De Reyniès; Augusto Villanueva; Julien Calderaro; Sandra Rebouissou; Gabrielle Couchy; Thomas Decaens; Dominique Franco; Sandrine Imbeaud; Francis Rousseau; Daniel Azoulay; Jean Saric; Jean-Frédéric Blanc; Charles Balabaud; Paulette Bioulac-Sage; Alexis Laurent; Pierre Laurent-Puig; Josep M Llovet; Jessica Zucman-Rossi
Journal:  Gastroenterology       Date:  2013-04-06       Impact factor: 22.682

7.  Sorafenib in advanced hepatocellular carcinoma.

Authors:  Josep M Llovet; Sergio Ricci; Vincenzo Mazzaferro; Philip Hilgard; Edward Gane; Jean-Frédéric Blanc; Andre Cosme de Oliveira; Armando Santoro; Jean-Luc Raoul; Alejandro Forner; Myron Schwartz; Camillo Porta; Stefan Zeuzem; Luigi Bolondi; Tim F Greten; Peter R Galle; Jean-François Seitz; Ivan Borbath; Dieter Häussinger; Tom Giannaris; Minghua Shan; Marius Moscovici; Dimitris Voliotis; Jordi Bruix
Journal:  N Engl J Med       Date:  2008-07-24       Impact factor: 91.245

Review 8.  Advances in molecular classification and precision oncology in hepatocellular carcinoma.

Authors:  Sandra Rebouissou; Jean-Charles Nault
Journal:  J Hepatol       Date:  2020-02       Impact factor: 25.083

9.  Ramucirumab after sorafenib in patients with advanced hepatocellular carcinoma and increased α-fetoprotein concentrations (REACH-2): a randomised, double-blind, placebo-controlled, phase 3 trial.

Authors:  Andrew X Zhu; Yoon-Koo Kang; Chia-Jui Yen; Richard S Finn; Peter R Galle; Josep M Llovet; Eric Assenat; Giovanni Brandi; Marc Pracht; Ho Yeong Lim; Kun-Ming Rau; Kenta Motomura; Izumi Ohno; Philippe Merle; Bruno Daniele; Dong Bok Shin; Guido Gerken; Christophe Borg; Jean-Baptiste Hiriart; Takuji Okusaka; Manabu Morimoto; Yanzhi Hsu; Paolo B Abada; Masatoshi Kudo
Journal:  Lancet Oncol       Date:  2019-01-18       Impact factor: 41.316

10.  Hepatocellular Carcinoma Demonstrates Heterogeneous Growth Patterns in a Multicenter Cohort of Patients With Cirrhosis.

Authors:  Nicole E Rich; Binu V John; Neehar D Parikh; Ian Rowe; Neil Mehta; Gaurav Khatri; Smitha M Thomas; Munazza Anis; Mishal Mendiratta-Lala; Christopher Hernandez; Mobolaji Odewole; Latha T Sundaram; Venkata R Konjeti; Shishir Shetty; Tahir Shah; Hao Zhu; Adam C Yopp; Yujin Hoshida; Francis Y Yao; Jorge A Marrero; Amit G Singal
Journal:  Hepatology       Date:  2020-10-25       Impact factor: 17.425
View more
  19 in total

Review 1.  Overdiagnosis of hepatocellular carcinoma: Prevented by guidelines?

Authors:  Nicole E Rich; Amit G Singal
Journal:  Hepatology       Date:  2022-01-18       Impact factor: 17.425

Review 2.  Emerging liquid biopsy techniques for early detection of hepatocellular carcinoma, prognostication, and disease monitoring.

Authors:  Ashwini Arvind; Amit G Singal
Journal:  Clin Liver Dis (Hoboken)       Date:  2022-07-22

3.  Glycopeptides with Sialyl Lewis Antigen in Serum Haptoglobin as Candidate Biomarkers for Nonalcoholic Steatohepatitis Hepatocellular Carcinoma Using a Higher-Energy Collision-Induced Dissociation Parallel Reaction Monitoring-Mass Spectrometry Method.

Authors:  Yu Lin; Jianhui Zhu; Jie Zhang; Jianliang Dai; Suyu Liu; Ana Arroyo; Marissa Rose; Amit G Singal; Neehar D Parikh; David M Lubman
Journal:  ACS Omega       Date:  2022-06-22

4.  Personalized statistical learning algorithms to improve the early detection of cancer using longitudinal biomarkers.

Authors:  Nabihah Tayob; Ziding Feng
Journal:  Cancer Biomark       Date:  2022       Impact factor: 3.828

5.  Associations of Ultrasound LI-RADS Visualization Score With Examination, Sonographer, and Radiologist Factors: Retrospective Assessment in Over 10,000 Examinations.

Authors:  David T Fetzer; Travis Browning; Yin Xi; Takeshi Yokoo; Amit G Singal
Journal:  AJR Am J Roentgenol       Date:  2021-12-15       Impact factor: 6.582

6.  Multicenter Randomized Clinical Trial of a Mailed Outreach Strategy for Hepatocellular Carcinoma Surveillance.

Authors:  Amit G Singal; Sarah Reddy; Himani Radadiya Aka Patel; Deyaun Villarreal; Aisha Khan; Yan Liu; Vanessa Cerda; Nicole E Rich; Caitlin C Murphy; Jasmin A Tiro; Jennifer R Kramer; Ruben Hernaez
Journal:  Clin Gastroenterol Hepatol       Date:  2021-12-10       Impact factor: 13.576

Review 7.  Rational HCC screening approaches for patients with NAFLD.

Authors:  Amit G Singal; Hashem B El-Serag
Journal:  J Hepatol       Date:  2021-09-09       Impact factor: 25.083

8.  Doylestown Plus and GALAD Demonstrate High Sensitivity for HCC Detection in Patients With Cirrhosis.

Authors:  Amit G Singal; Nabihah Tayob; Anand Mehta; Jorge A Marrero; Qingchun Jin; Joy Lau; Neehar D Parikh
Journal:  Clin Gastroenterol Hepatol       Date:  2021-04-20       Impact factor: 13.576

9.  DETECT: Development of Technologies for Early HCC Detection.

Authors:  Jihane N Benhammou; Nicole E Rich; George Cholankeril; Peng Zhang; Weihua Zeng; Shuyun Rao; Nabihah Tayob
Journal:  Gastroenterology       Date:  2022-03-23       Impact factor: 33.883

10.  Unannotated small RNA clusters associated with circulating extracellular vesicles detect early stage liver cancer.

Authors:  Johann von Felden; Teresa Garcia-Lezana; Navneet Dogra; Edgar Gonzalez-Kozlova; Mehmet Eren Ahsen; Amanda Craig; Stacey Gifford; Benjamin Wunsch; Joshua T Smith; Sungcheol Kim; Jennifer E L Diaz; Xintong Chen; Ismail Labgaa; Philipp Haber; Reena Olsen; Dan Han; Paula Restrepo; Delia D'Avola; Gabriela Hernandez-Meza; Kimaada Allette; Robert Sebra; Behnam Saberi; Parissa Tabrizian; Amon Asgharpour; Douglas Dieterich; Josep M Llovet; Carlos Cordon-Cardo; Ash Tewari; Myron Schwartz; Gustavo Stolovitzky; Bojan Losic; Augusto Villanueva
Journal:  Gut       Date:  2021-07-28       Impact factor: 31.793
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.